Bordetella pertussis is a pathogen-causing whooping cough (pertussis) in humans.
Although vaccination against the disease is effective, the bacterium is still circulating among …

Pertussis (whooping cough) epidemics persist globally despite high vaccine coverage
among infants and young children. The resurgence of pertussis in high-income countries is …

As more original molecular protocols and subsequent modifications are described in the
literature, it has become difficult for those not directly involved in the development of these …

Background Current and past pertussis epidemiology in the two parts of Germany is
compared in the context of different histories of vaccination recommendations and coverage …

OBJECTIVES: Pertussis continues causing significant morbidity and mortality worldwide.
Although its epidemiology has been studied in many developed countries, the current …

In Spain, whole cell pertussis vaccination started in 1975, with three doses before the age of
6-7 months. Doses at 15-18 months and 4-6 years were introduced in 1996 and 2001 …

Objective Countries routinely offering acellular pertussis vaccine, where long-term protection
is not sustained, have the challenge of selecting an optimal schedule to minimise disease …

Background: In Germany, whole-cell pertussis vaccines were rapidly replaced by high-
concentration acellular pertussis-containing vaccines (3+ 1 doses from 2 months of age) …

High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis
among European countries, 2010: integr Page 1 1 www.eurosurveillance.org Research …

Introduction Pertussis is a communicable disease that primarily affects infants. Vaccination
has led to an important reduction in the incidence of the disease, however, resurgence of the …